BICYCLE THERAPEUTICS PLC - Common Stock (BCYC)
CUSIP: 088786108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,984,905
- Total 13F shares
- 41,200,406
- Share change
- -534,198
- Total reported value
- $286,338,478
- Put/Call ratio
- 31%
- Price per share
- $6.95
- Number of holders
- 110
- Value change
- -$7,404,258
- Number of buys
- 66
- Number of sells
- 34
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
22%
|
10,885,357
|
$92,416,681 | — | 31 Mar 2025 | |
| Kate Bingham |
3/4/5
|
Director |
—
class O/S missing
|
1,870,379
|
$32,731,633 | — | 13 Jul 2021 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
3.9%
from 13D/G
|
3,692,069
|
$31,345,666 | — | 31 Mar 2025 | |
| FCPM III SERVICES B.V. |
13F
|
Company |
6.9%
|
3,452,330
|
$29,310,282 | — | 31 Mar 2025 | |
| Forbion Growth Opportunities Fund II Cooperatief U.A. |
13D/G
|
— |
7.3%
|
3,452,330
|
$28,343,629 | $0 | 21 Nov 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5.3%
|
2,672,000
|
$22,685,280 | — | 31 Mar 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
5.3%
|
2,657,305
|
$22,560,519 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
3.6%
|
1,812,752
|
$15,390,264 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.1%
|
1,536,584
|
$13,046,000 | — | 31 Mar 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
2.6%
|
1,293,753
|
$10,983,963 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
2.4%
|
1,219,688
|
$10,355,000 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
2.4%
|
1,205,207
|
$10,232,282 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
2.4%
|
1,203,244
|
$9,625,952 | -$12,943,416 | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.2%
|
1,093,477
|
$9,283,620 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
999,837
|
$8,488,617 | — | 31 Mar 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.8%
|
910,000
|
$7,725,900 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.3%
|
631,260
|
$5,359,398 | — | 31 Mar 2025 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
1.2%
|
576,343
|
$4,893,153 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
563,559
|
$4,784,616 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
1.1%
|
553,682
|
$4,700,760 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.91%
|
453,428
|
$3,849,604 | — | 31 Mar 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.82%
|
408,889
|
$3,471,468 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.73%
|
363,751
|
$3,088,246 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.65%
|
322,876
|
$2,741,218 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.6%
|
301,500
|
$2,559,735 | — | 31 Mar 2025 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.58%
|
287,599
|
$2,441,716 | — | 31 Mar 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.53%
|
265,693
|
$2,255,734 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.5%
|
248,934
|
$2,113,450 | — | 31 Mar 2025 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.43%
|
215,900
|
$1,833,000 | — | 31 Mar 2025 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.43%
|
214,278
|
$1,819,220 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.39%
|
193,092
|
$1,639,351 | — | 31 Mar 2025 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.34%
|
171,695
|
$1,457,691 | — | 31 Mar 2025 | |
| Nicholas Keen |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
mixed-class rows
|
125,024
mixed-class rows
|
$1,355,631 | — | 03 Jul 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.3%
|
148,722
|
$1,262,650 | — | 31 Mar 2025 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.3%
|
148,129
|
$1,258,000 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.28%
|
138,249
|
$1,173,734 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
135,658
|
$1,167,188 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
130,070
|
$1,104,294 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.25%
|
126,062
|
$1,065,000 | — | 31 Mar 2025 | |
| Santiago Arroyo |
3/4/5
|
CHIEF DEVELOPMENT OFFICER |
—
mixed-class rows
|
197,627
mixed-class rows
|
$973,013 | — | 02 Jan 2025 | |
| Nigel Crockett |
3/4/5
|
CHIEF BUSINESS OFFICER |
—
mixed-class rows
|
72,803
mixed-class rows
|
$753,032 | — | 02 Jan 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.17%
|
85,653
|
$727,194 | — | 31 Mar 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.16%
|
81,559
|
$692,436 | — | 31 Mar 2025 | |
| Pierre Legault |
3/4/5
|
Director |
—
mixed-class rows
|
71,000
mixed-class rows
|
$690,000 | — | 02 Jan 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.16%
|
80,799
|
$685,984 | — | 31 Mar 2025 | |
| Dominic Smethurst |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
71,699
mixed-class rows
|
$642,233 | — | 03 Jan 2023 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
72,702
|
$617,240 | — | 31 Mar 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.14%
|
68,943
|
$585,326 | — | 31 Mar 2025 | |
| Richard N. Kender |
3/4/5
|
Director |
—
mixed-class rows
|
35,500
mixed-class rows
|
$570,860 | — | 02 Jan 2025 | |
| Lee Kalowski |
3/4/5
|
President and CFO |
—
class O/S missing
|
30,309
|
$530,408 | — | 03 Apr 2023 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) as of Q2 2025
As of 30 Jun 2025,
BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,200,406 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Siren, L.L.C., Point72 Asset Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, Long Focus Capital Management, LLC, and Deep Track Capital, LP.
This page lists
110
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
95
Q2 2025 holders
110
Holder diff
15
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.